According to Gilead Sciences's latest financial reports the company's total assets are $62.12 B. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2023-12-31 | $62.12 B | -1.66% |
2022-12-31 | $63.17 B | -7.04% |
2021-12-31 | $67.95 B | -0.67% |
2020-12-31 | $68.40 B | 11% |
2019-12-31 | $61.62 B | -3.22% |
2018-12-31 | $63.67 B | -9.4% |
2017-12-31 | $70.28 B | 23.35% |
2016-12-31 | $56.97 B | 10.17% |
2015-12-31 | $51.71 B | 49.19% |
2014-12-31 | $34.66 B | 53.52% |
2013-12-31 | $22.57 B | 6.3% |
2012-12-31 | $21.23 B | 22.75% |
2011-12-31 | $17.30 B | 49.26% |
2010-12-31 | $11.59 B | 19.53% |
2009-12-31 | $9.69 B | 39.81% |
2008-12-31 | $6.93 B | 18.89% |
2007-12-31 | $5.83 B | 42.8% |
2006-12-31 | $4.08 B | 8.49% |
2005-12-31 | $3.76 B | 74.69% |
2004-12-31 | $2.15 B | 38.67% |
2003-12-31 | $1.55 B | 20.69% |
2002-12-31 | $1.28 B | 62.08% |
2001-12-31 | $0.79 B |
Company | Total assets | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $167.55 B | 169.71% | ๐บ๐ธ USA |
Pfizer PFE | $226.50 B | 264.59% | ๐บ๐ธ USA |
AbbVie ABBV | $134.71 B | 116.84% | ๐บ๐ธ USA |
Eli Lilly LLY | $64.00 B | 3.03% | ๐บ๐ธ USA |
Amgen AMGN | $97.15 B | 56.38% | ๐บ๐ธ USA |
Biogen BIIB | $26.84 B | -56.79% | ๐บ๐ธ USA |
Illumina ILMN | $10.11 B | -83.72% | ๐บ๐ธ USA |
Vertex Pharmaceuticals VRTX | $22.73 B | -63.41% | ๐บ๐ธ USA |
Merck MRK | $106.67 B | 71.71% | ๐บ๐ธ USA |